96 related articles for article (PubMed ID: 1215372)
21. Studies on the treatment of experimental tuberculosis of the guinea pig with intermittent doses of isoniazid.
Dickinson JM; Aber VR; Mitchison DA
Tubercle; 1973 Sep; 54(3):211-24. PubMed ID: 4204112
[No Abstract] [Full Text] [Related]
22. [Immunologic reactivity and healing reactions in animals with experimental tuberculosis as affected by chemotherapy].
Sibirnaia RI; Podusovskiĭ VF; Manastyrskaia OS
Probl Tuberk; 1985; (5):56-9. PubMed ID: 4048112
[No Abstract] [Full Text] [Related]
23. [Changes in the fibronectin level of the blood and bronchoalveolar lavage fluid in experimental tuberculosis in guinea pigs].
Kaminskaia GO; Grigor'eva EV; Gedymin LE; Sivakov AE
Probl Tuberk; 1993; (1):50-4. PubMed ID: 8327442
[TBL] [Abstract][Full Text] [Related]
24. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis.
Pandey R; Khuller GK
Tuberculosis (Edinb); 2005 Jul; 85(4):227-34. PubMed ID: 15922668
[TBL] [Abstract][Full Text] [Related]
25. [Changes of isoniazid concentrations in guinea pig blood and organs after various routes of drug administration].
Kaminskaia GO; Firsova VA; Gubkina MF; Efimova LN
Probl Tuberk; 1997; (2):45-7. PubMed ID: 9235591
[TBL] [Abstract][Full Text] [Related]
26. [Dynamics of the experimental tuberculous process under the influence of nerobol].
Gomoliako IV; Bal'tseva LB; Klimenko MT
Probl Tuberk; 1980 Jan; (1):60-3. PubMed ID: 7367427
[No Abstract] [Full Text] [Related]
27. The suitability of new drugs for intermittent chemotherapy of tuberculosis. An experimental study.
Dickinson JM
Scand J Respir Dis Suppl; 1969; 69():91-8. PubMed ID: 4190279
[No Abstract] [Full Text] [Related]
28. [Effect of 4-chloroanilid of 5-chlorosalicylic acid on experimental tuberculosis in guinea pigs].
Kostrzeński W; Paklerska-Pobratyn H
Gruzlica; 1967 Feb; 35(2):153-8. PubMed ID: 6045025
[No Abstract] [Full Text] [Related]
29. [Splenin in the therapy of diabetic ketoacidosis].
Shcherbak AV; Iavorskiĭ LA; Derevianko LP
Vrach Delo; 1982 Jun; (6):13-5. PubMed ID: 6810550
[No Abstract] [Full Text] [Related]
30. [Effect of phthivazid and isoniazid on the macro- and microorganisms in tubercular infections].
Sodikov ES; Kazakov KS; Gapon'ko LA
Probl Tuberk; 1970; 48(8):58-61. PubMed ID: 4924910
[No Abstract] [Full Text] [Related]
31. [Question of bactericidal effect of a combination of maximally tolerable doses of INH, Myambutol and Rifadin on experimental tuberculosis].
Djurisić M; Davidović C; Leposavić M; Jovancvić M; Marković L; Popović S
Plucne Bolesti Tuberk; 1973; 25(3):251-6. PubMed ID: 4210992
[No Abstract] [Full Text] [Related]
32. [Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs].
Bondarev IM; Ivanov VL; Novoselova VP; Kovaleva LA; Shtegel'man LA
Antibiotiki; 1984 Jun; 29(6):430-4. PubMed ID: 6476805
[TBL] [Abstract][Full Text] [Related]
33. [Combined application of mycobacteriophages and tubazid in experimental tuberculosis].
Sharov GI; Gel'berg SI; Peschanskiĭ VS
Probl Tuberk; 1974; (12):67-71. PubMed ID: 4445140
[No Abstract] [Full Text] [Related]
34. [Concentration of isoniazid-H3 in the blood and tissues of experimental animals].
Cherednichenko LP; Klebanova AA
Probl Tuberk; 1970; 48(9):69-72. PubMed ID: 5518277
[No Abstract] [Full Text] [Related]
35. [Effect of isoniazid and of a complex compound of cobalt with pyridoxine on rabbits infected with tuberculosis].
Sodikov ES; Gapon'ko LA
Farmakol Toksikol; 1972; 35(2):234-7. PubMed ID: 5017977
[No Abstract] [Full Text] [Related]
36. [Therapeutic properties of a prolonged-action preparation of isoniazid].
Ivaniuta OM; Maliuk VI; Sokirko TA; Klimenko MT; Suslov EI
Probl Tuberk; 1988; (3):47-50. PubMed ID: 3387395
[No Abstract] [Full Text] [Related]
37. Intermittent rifampicin treatment in experimental tuberculosis.
Algeorge G; Rudescu D; Petre A
Arch Roum Pathol Exp Microbiol; 1973 Jun; 32(2):277-86. PubMed ID: 4584318
[No Abstract] [Full Text] [Related]
38. [Effect of levamisole, splenin and thymosterin A on the immunocompetent cells of tuberculosis patients].
Kogosova LS; Chernushenko EF; Petrashenko AI
Probl Tuberk; 1982 May; (5):60-4. PubMed ID: 7111259
[No Abstract] [Full Text] [Related]
39. [Intermittent method for the treatment of experimental tuberculosis with streptomycin only and streptomycin combined with methazid].
Makeeva OO; Pershin GN
Probl Tuberk; 1965; 43(5):71-8. PubMed ID: 5892890
[No Abstract] [Full Text] [Related]
40. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
Sharma A; Sharma S; Khuller GK
J Antimicrob Chemother; 2004 Oct; 54(4):761-6. PubMed ID: 15329364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
